Celcuity CELC
NASDAQ CELC
$95.70 -0.73 (-0.76%)
As of: Sep 4, 2026 · 3:59 PM EDT

Celcuity (CELC) Amortization of Deferred Charges (2021 - 2026)

Celcuity's (CELC) quarterly Amortization of Deferred Charges came in at $1.3 million in Q4 2025, up 130.67% YoY from $551000.0 in Q4 2024, and up 63.37% on a QoQ basis from $778000.0 in Q3 2025.

Analysis

Celcuity (CELC) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends

Celcuity (CELC) has 5 years of Amortization of Deferred Charges data on file, last reported at $1.3 million in Q4 2025.

  • Quarterly Amortization of Deferred Charges rose 130.67% year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.1 million (up 135.69% YoY) and the FY2025 annual result came in at $3.1 million, up 135.69% from the prior year.
  • Amortization of Deferred Charges rose to $1.3 million in Q4 2025, from $778000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $1.3 million in Q4 2025 to a low of $57004.0 in Q1 2023.
  • A 5-year average of $293986.6 and a median of $99828.5 in 2022 frame the typical range for Amortization of Deferred Charges.
  • Annual changes were most pronounced in 2023 — Amortization of Deferred Charges sank 42.81% — and 2024, when it jumped 763.46%.
  • Tracing CELC's Amortization of Deferred Charges over 5 years: stood at $94460.0 in 2021, then gained by 18.12% to $111573.0 in 2022, then plunged by 42.81% to $63813.0 in 2023, then jumped by 763.46% to $551000.0 in 2024, then soared by 130.67% to $1.3 million in 2025.
  • The last three Amortization of Deferred Charges figures came in at $1.3 million (Q4 2025), $778000.0 (Q3 2025), and $537000.0 (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Celcuity 5.25 Bn 5.25 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 200,000.00
Dec 31, 2025 1.27 Mn
Sep 30, 2025 778,000.00
Jun 30, 2025 537,000.00
Mar 31, 2025 551,000.00
Dec 31, 2024 551,000.00
Sep 30, 2024 478,000.00
Jun 30, 2024 237,000.00
Mar 31, 2024 65,000.00
Dec 31, 2023 63,813.00
Sep 30, 2023 61,721.00
Jun 30, 2023 59,214.00
Mar 31, 2023 57,004.00
Dec 31, 2022 111,573.00
Sep 30, 2022 104,645.00
Jun 30, 2022 84,527.00
Mar 31, 2022 95,012.00
Dec 31, 2021 94,460.00
Sep 30, 2021 91,790.00